NDC 69339-160-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69339-160
- Requested NDC
- 69339-160-01
- Package NDCs from labels
- 69339-160-01, 69339-160-16, 69339-160-17, 69339-160-18, 69339-160-19
- Manufacturer
- Natco Pharma USA LLC | Strides Pharma, Inc
- Effective date
- 2026-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - Natco Pharma USA LLC | Strides Pharma, Inc | Natco Pharma USA LLC | Strides Pharma, Inc | 2026-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69339-160-01 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 69339-160-16 | Megestrol Acetate | 3 in 1 CASE | SUSPENSION | 3 | 2 | |
| 69339-160-16 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-17 | Megestrol Acetate | 4 in 1 CASE | SUSPENSION | 4 | 2 | |
| 69339-160-17 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 5 in 1 CASE | SUSPENSION | 5 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 CASE | SUSPENSION | 10 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69339-160-01 | ML - Milliliter | 69339-160 | 67edb6da-5e2c-4fcc-8a4a-3b098aaff6eb | 1 | 2023-09-05 |
| 69339-160-16 | ML - Milliliter | 69339-160 | 27f6e6c7-08d3-442e-b959-3a663f185453 | 1 | 2023-09-05 |
| 69339-160-17 | ML - Milliliter | 69339-160 | 31b3dcc7-2913-4c24-b3a6-640158ec6c37 | 1 | 2023-09-05 |
| 69339-160-18 | ML - Milliliter | 69339-160 | 59fcc138-63c5-45d5-b946-93f453f55056 | 1 | 2023-09-05 |
| 69339-160-19 | ML - Milliliter | 69339-160 | da7e552a-6eec-4c7f-993b-b3d609d66d99 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | National Vitamin Company | 0c66642c-82cb-42cd-82bb-5f95852cc5d1 | 2024-12-12 | Warnings | F05Q2T2JA0 |
| Laxacin | DOCUSATE SODIUM AND SENNOSIDES | Alexso, Inc | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 2024-12-04 | Warnings | F05Q2T2JA0 |
| Burts Bees Rapid Rescue Cold Sore Treatment | CAMPHOR, GLYCERIN | Burts Bees | 9f89735d-205f-4d3e-a1e1-ecc96284fe98 | 2024-12-03 | Warnings | PDC6A3C0OX |
| SENNA-PLUS | SENNOSIDES AND DOCUSATE SODIUM | Geri-Care Pharmaceutical Corp | 8a0882ed-f623-2359-e053-2995a90a6f98 | 2024-11-28 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 50 MG | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | af7533e6-8b06-48a4-940e-7ecb57b24b59 | 2024-11-25 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | a923e5ca-86fd-4bf9-9931-180ddfdeae66 | 2024-11-25 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | 7cf1df18-d658-4bff-8a62-365fc5656942 | 2024-11-25 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 100mg | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | c5bdfbfc-d24a-4088-9b60-ecea8120ff43 | 2024-11-25 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | b10fdf50-289e-41f3-9b83-a4e4dd892f88 | 2024-11-21 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | 85c64624-428d-46fa-8071-f42b8feec049 | 2024-11-21 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 33251cb7-b7b1-4f6c-9e10-4fa64cbf03a0 | 2024-11-21 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER | DOCUSATE SODIUM | Walgreen Co. | d8d97ca5-5131-4620-8ce9-bc3f9d5c0ab5 | 2024-11-21 | Warnings | F05Q2T2JA0 |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | ce42122f-8087-471f-b0a3-5524bdbd4526 | 2024-11-19 | Warnings, Adverse reactions | 2968PHW8QP |
| Stool Softener | DOCUSATE SODIUM 100MG | PuraCap Pharmaceutical LLC | 272c86f1-f229-2ebf-e063-6394a90a3471 | 2024-11-18 | Warnings | F05Q2T2JA0 |
| TRICITRATES | POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad | 2024-11-15 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | RB Health Mexico, S.A. de C.V. | 151b9bc9-1a6e-4401-ae58-4b4210ab4505 | 2024-11-15 | Warnings | 2968PHW8QP |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Pharmaceutical Associates, Inc. | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2024-11-13 | Adverse reactions | 1Q73Q2JULR |
| Focus | ADENOSINUM CYCLOPHOSPHORICUM, ADRENALINUM, AETHUSA CYNAPIUM, ALPHA-KETOGLUTARICUM ACIDUM, AMBRA GRISEA, BARYTA CARBONICA, CANDIDA ALBICANS, CARBONEUM SULPHURATUM, CEREBRUM SUIS, GINKGO BILOBA, HELLEBORUS NIGER, HYPOTHALAMUS SUIS, HYOSCYAMUS NIGER, IODIUM, PHOSPHORUS, SACCHARUM OFFICINALE, SARCOLACTICUM ACID, SILICEA, TARENTULA HISPANA, VERATRUM ALBUM | Deseret Biologicals, Inc. | e014e6b6-a07a-4170-b9af-f477da71597d | 2024-11-13 | Warnings | C151H8M554 |
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 122486e9-74dd-4181-97d1-0b07688280f4 | 2024-11-06 | Warnings | F05Q2T2JA0 |
| Stratuscare Adult Glycerin | GLYCERIN | Stratus Pharmaceuticals | 3e1935da-5c1f-4942-98dd-320fade82321 | 2024-11-04 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.